Report Summary by Laura M. Bogart that describes medical mistrust as a key contributor to racial/ethnic health and healthcare disparities in the U.S, the serious health consequences for people living with and at risk for HIV, and how medical mistrust also can affect views about HIV.
This factsheet describes the HIV Prevention Trials Network (HPTN) 083. a randomized active-controlled, double-blind clinical trial that began in December 2016. The study has compared the safety and efficacy of two drugs for use as PrEP among a Population at increased risk of HIV infection.
This policy brief describes how re-entry has been associated with increased, illness, mortality, and risky health behaviors. The brief highlights the process of community re-entry presenting a crucial opportunity to link individuals with needed health and social services. This brief looks to HIV, a pandemic predating COVID-19, in order to draw broader lessons for addressing the needs of incarcerated populations in the United States during re-entry.
This policy brief describes the criminalization of commercial sex trade and regulatory frameworks seeking to regulate it differ across the globe. These efforts are described into four models of criminalization and regulation which include criminalize sex trade, criminalize clients (also known as the Nordic or End Demand model), regulate sex trade, and decriminalize sex trade.
This factsheet describes contingency management (CM) as a behavioral intervention that promotes healthy behavior using positive reinforcement in the form of rewards. CM was adopted by public health practitioners and policymakers to help bring about a variety of positive health outcomes, including employment seeking behaviors, starting and continuing to take prescribed medications for the prevention of HIV and remaining engaged in HIV care.
This policy brief referred to as the White Paper describes how Black men who have sex with men (BMSM), lag behind in PrEP use despite the fact that they are a population disproportionately affected by HIV/AIDS and represent one of the single largest groups of new cases in the US each year.
The Use of HIV Over-the Counter (OTC) Test in California from April to September 2013 – Policy Brief
This policy brief examines the distribution, usage, and results of the HIV OTC test for a six-month period (April 1, 2013, through September 30, 2013) to determine how the HIV OTC test is being used thus far in California, an initial start-up period. This frame was selected as most manufacturing and distribution challenges had been overcome, and the HIV OTC test was generally available to consumers throughout California.
This policy brief describes the disproportionate prevalence of HIV among individuals in the correctional system. This policy brief elucidates the problem and recommends policies that prisons and jails in California could undertake to reduce new infections and treat existing ones.